WWM
BIVV

Willingdon Wealth Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Willingdon Wealth Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-65
Closed -$4K – 404
2017
Q4 		$4K Hold
65
– – ﹤0.01% 308
2017
Q3 		$4K Buy
+65
New +$3.81K ﹤0.01% 270

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Willingdon Wealth Management's BIVV Position: Q1 2018 in Review

Willingdon Wealth Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 65 shares — an estimated $4K sold.

Willingdon Wealth Management first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $4K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Willingdon Wealth Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Willingdon Wealth Management sold 65 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $4K.
  • Willingdon Wealth Management first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Willingdon Wealth Management's Bioverativ Inc. Common Stock position peaked at $4K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Willingdon Wealth Management's 13F filing for Q1 2018, filed 8 May 2018.